Exenatide is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2.
中文别名:
依克那肽; 醋酸艾塞那肽 EXENATIDEACETATE; 醋酸艾塞那肽;
物化属性:
PSA:1812.35000
LOGP:-2.07850